Skip to main content
https://pbs.twimg.com/media/Frlh2aWWwAEhhnD.jpg
Biosimilars back on the radar for 2023. Expect to see 17 in rheum. #RNL2023 @RheumNow https://t.co/SNYNM8nmD2
Dr. Rachel Tate
19-03-2023
×